Objectives: This study evaluates the impact of systemic medications and polypharmacy on unstimulated (UWS) and chewing-stimulated whole saliva (SWS) flow rates in patients with xerostomia. Material and methods: This cross-sectional multicenter study is based on data of patients referred to five oral medicine outpatient practices in Europe and USA from January 2000 and April 2014. Relevant demographic, social, medical history and current medications were collected. Results: The study included 1144 patients, 972 (85%) females, with a mean (SD) age of 59 (14.1) years. In unmatched patients, the UWS flow rate was lower in patients taking a medication (vs. not taking a medication) from the following drug categories: opioid analgesics, anticonvul...
Abstract Objective: The aim was to investigate how sedative load and the total number of drugs used...
Background: Saliva is secreted by the major and minor salivary glands. There are a number of physiol...
Assessing the clinical effectiveness of a topical sialogogue on spray (malic acid, 1%) in the treatm...
Objectives: This study evaluates the impact of systemic medications and polypharmacy on unstimulated...
Objectives: This study evaluates the impact of systemic medications and polypharmacy on unstimulated...
The aims of this systematic review are (1) to compare the prevalence of xerostomia and hyposalivatio...
ObjectivesThe aim of this study was to examine the association between medication exposure and (1) u...
ObjectiveSide-effects of medications cause xerostomia. There have been cases where a medication has ...
The purpose of the present study was to investigate the differences in salivary flow rates and dry m...
Objective: The aim of this study was to evaluate the risk factors associated with xerostomia and hyp...
Objective. This study aimed to systematically review the available literature on the clinical implic...
Objective. This study aimed to systematically review the available literature on the clinical implic...
BACKGROUND: Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dry...
Objectives Medication-induced salivary gland dysfunction (MISGD) causes significant morbidity result...
Objectives Medication-induced salivary gland dysfunction (MISGD) causes significant morbidity result...
Abstract Objective: The aim was to investigate how sedative load and the total number of drugs used...
Background: Saliva is secreted by the major and minor salivary glands. There are a number of physiol...
Assessing the clinical effectiveness of a topical sialogogue on spray (malic acid, 1%) in the treatm...
Objectives: This study evaluates the impact of systemic medications and polypharmacy on unstimulated...
Objectives: This study evaluates the impact of systemic medications and polypharmacy on unstimulated...
The aims of this systematic review are (1) to compare the prevalence of xerostomia and hyposalivatio...
ObjectivesThe aim of this study was to examine the association between medication exposure and (1) u...
ObjectiveSide-effects of medications cause xerostomia. There have been cases where a medication has ...
The purpose of the present study was to investigate the differences in salivary flow rates and dry m...
Objective: The aim of this study was to evaluate the risk factors associated with xerostomia and hyp...
Objective. This study aimed to systematically review the available literature on the clinical implic...
Objective. This study aimed to systematically review the available literature on the clinical implic...
BACKGROUND: Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dry...
Objectives Medication-induced salivary gland dysfunction (MISGD) causes significant morbidity result...
Objectives Medication-induced salivary gland dysfunction (MISGD) causes significant morbidity result...
Abstract Objective: The aim was to investigate how sedative load and the total number of drugs used...
Background: Saliva is secreted by the major and minor salivary glands. There are a number of physiol...
Assessing the clinical effectiveness of a topical sialogogue on spray (malic acid, 1%) in the treatm...